Correlation Between Morgan Stanley and Orient Pharma

Can any of the company-specific risk be diversified away by investing in both Morgan Stanley and Orient Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morgan Stanley and Orient Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morgan Stanley Direct and Orient Pharma Co, you can compare the effects of market volatilities on Morgan Stanley and Orient Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morgan Stanley with a short position of Orient Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morgan Stanley and Orient Pharma.

Diversification Opportunities for Morgan Stanley and Orient Pharma

0.61

Correlation Coefficient

Morgan Stanley  Orient Pharma

Poor diversification

The 3 months correlation between Morgan and Orient is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Morgan Stanley Direct and Orient Pharma Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orient Pharma and Morgan Stanley is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morgan Stanley Direct are associated (or correlated) with Orient Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orient Pharma has no effect on the direction of Morgan Stanley i.e., Morgan Stanley and Orient Pharma go up and down completely randomly.

Pair Corralation between Morgan Stanley and Orient Pharma

Given the investment horizon of 90 days Morgan Stanley is expected to generate 5.89 times less return on investment than Orient Pharma. But when comparing it to its historical volatility, Morgan Stanley Direct is 4.68 times less risky than Orient Pharma. It trades about 0.11 of its potential returns per unit of risk. Orient Pharma Co is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2,590  in Orient Pharma Co on September 24, 2024 and sell it today you would earn a total of  1,110  from holding Orient Pharma Co or generate 42.86% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Morgan Stanley Direct  vs.  Orient Pharma Co

Morgan Stanley Direct

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morgan Stanley Direct are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite quite unsteady fundamental indicators, Morgan Stanley may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Orient Pharma

Risk-Adjusted Performance

11 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Orient Pharma Co are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Orient Pharma showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Morgan Stanley and Orient Pharma

The main advantage of trading using opposite Morgan Stanley and Orient Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morgan Stanley position performs unexpectedly, Orient Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orient Pharma will offset losses from the drop in Orient Pharma's long position.

The idea behind Morgan Stanley Direct and Orient Pharma Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.